These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2679028)

  • 21. New recommendations for the diagnosis and treatment of plasma lipid abnormalities.
    Schaefer EJ
    Nutr Rev; 1993 Aug; 51(8):246-53. PubMed ID: 8302497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-density lipoproteins and risk for coronary artery disease.
    Ballantyne CM
    Am J Cardiol; 1998 Nov; 82(9A):3Q-12Q. PubMed ID: 9819098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease.
    Hearn JA; DeMaio SJ; Roubin GS; Hammarstrom M; Sgoutas D
    Am J Cardiol; 1990 Nov; 66(17):1176-80. PubMed ID: 2146869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease.
    Genest J; Jenner JL; McNamara JR; Ordovas JM; Silberman SR; Wilson PW; Schaefer EJ
    Am J Cardiol; 1991 May; 67(13):1039-145. PubMed ID: 1827234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein, low-density lipoprotein and coronary artery disease.
    Wilson PW
    Am J Cardiol; 1990 Sep; 66(6):7A-10A. PubMed ID: 2203248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. The experts panel.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):1-14. PubMed ID: 7712390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting.
    Nola KM; Gourley DR; Portner TS; Gourley GK; Solomon DK; Elam M; Regel B
    J Am Pharm Assoc (Wash); 2000; 40(2):166-73. PubMed ID: 10730020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of lipid metabolism in the prevention of coronary heart disease].
    Mathes P; Thiery J
    Z Kardiol; 2005; 94 Suppl 3():III/43-55. PubMed ID: 16258792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women.
    Hong MK; Romm PA; Reagan K; Green CE; Rackley CE
    Am J Cardiol; 1991 Dec; 68(17):1646-50. PubMed ID: 1746467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels.
    Ginsburg GS; Safran C; Pasternak RC
    Am J Cardiol; 1991 Jul; 68(2):187-92. PubMed ID: 2063780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.